Grants and Contributions:
Title:
Assay method development for enzyme activity, characterization and stability testing
Agreement Number:
996471
Agreement Value:
$170,819.00
Agreement Date:
Sep 6, 2022 - Apr 28, 2023
Description:
This project will involve the development of assay systems to test for and assess enzyme quality, purity and stability, as well as support for the development of monoclonal antibodies (for detection of both enzymes, EnzAO1 and EnzAO2) and preparation of technology transfer datasheets.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V7X 1L3
Reference Number:
172-2022-2023-Q3-996471
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
706842473
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The total amended value is -15,181 dollars.
Amendment Date
Mar 1, 2023
Recipient's Legal Name:
Avivo Biomedical Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: